IGM Other Assets vs Cash And Short Term Investments Analysis

IGMS Stock  USD 9.25  0.24  2.53%   
IGM Biosciences financial indicator trend analysis is infinitely more than just investigating IGM Biosciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IGM Biosciences is a good investment. Please check the relationship between IGM Biosciences Other Assets and its Cash And Short Term Investments accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IGM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.

Other Assets vs Cash And Short Term Investments

Other Assets vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IGM Biosciences Other Assets account and Cash And Short Term Investments. At this time, the significance of the direction appears to have strong relationship.
The correlation between IGM Biosciences' Other Assets and Cash And Short Term Investments is 0.79. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of IGM Biosciences, assuming nothing else is changed. The correlation between historical values of IGM Biosciences' Other Assets and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of IGM Biosciences are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Other Assets i.e., IGM Biosciences' Other Assets and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.79
Relationship DirectionPositive 
Relationship StrengthSignificant

Other Assets

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of IGM Biosciences balance sheet. This account contains IGM Biosciences investments that will expire within one year. These investments include stocks and bonds that can be liquidated by IGM Biosciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from IGM Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IGM Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IGM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.At this time, IGM Biosciences' Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 152.9 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (1.50) in 2024.
 2021 2022 2023 2024 (projected)
Reconciled Depreciation4.5M6.1M8.0M8.4M
Total Operating Expenses165.3M229.0M265.6M278.9M

IGM Biosciences fundamental ratios Correlations

0.790.92-0.340.950.970.94-0.79-0.80.70.880.950.890.821.00.960.940.560.950.970.810.650.950.881.00.87
0.790.90.010.80.690.89-0.44-0.990.230.570.880.911.00.760.720.870.90.870.750.930.940.630.980.770.96
0.920.9-0.30.840.830.99-0.6-0.890.460.720.980.990.910.890.860.970.750.890.890.880.820.770.930.90.92
-0.340.01-0.3-0.16-0.27-0.30.3-0.09-0.46-0.31-0.3-0.30.02-0.35-0.29-0.220.12-0.15-0.53-0.030.07-0.37-0.07-0.35-0.11
0.950.80.84-0.160.960.88-0.74-0.820.690.830.910.80.820.940.960.890.520.980.870.780.620.940.890.940.91
0.970.690.83-0.270.960.88-0.85-0.720.80.910.90.790.720.970.980.910.40.940.90.730.50.980.80.970.82
0.940.890.99-0.30.880.88-0.66-0.880.550.780.990.980.890.920.910.990.680.930.910.890.760.830.940.920.94
-0.79-0.44-0.60.3-0.74-0.85-0.660.48-0.92-0.98-0.65-0.53-0.49-0.8-0.76-0.73-0.15-0.77-0.78-0.66-0.25-0.87-0.59-0.8-0.58
-0.8-0.99-0.89-0.09-0.82-0.72-0.880.48-0.25-0.6-0.88-0.89-0.99-0.77-0.74-0.88-0.88-0.89-0.73-0.94-0.93-0.64-0.98-0.78-0.95
0.70.230.46-0.460.690.80.55-0.92-0.250.890.560.390.270.720.750.59-0.140.660.70.41-0.020.860.410.720.45
0.880.570.72-0.310.830.910.78-0.98-0.60.890.770.670.620.880.850.830.280.860.860.750.390.920.710.890.7
0.950.880.98-0.30.910.90.99-0.65-0.880.560.770.960.890.930.940.980.660.940.910.850.740.850.930.940.94
0.890.910.99-0.30.80.790.98-0.53-0.890.390.670.960.910.860.820.950.780.850.880.880.840.720.920.870.9
0.821.00.910.020.820.720.89-0.49-0.990.270.620.890.910.790.740.880.890.890.770.950.940.660.990.80.96
1.00.760.89-0.350.940.970.92-0.8-0.770.720.880.930.860.790.960.920.540.940.960.790.630.960.851.00.85
0.960.720.86-0.290.960.980.91-0.76-0.740.750.850.940.820.740.960.910.420.930.890.720.520.960.820.960.86
0.940.870.97-0.220.890.910.99-0.73-0.880.590.830.980.950.880.920.910.650.940.890.90.730.840.930.930.92
0.560.90.750.120.520.40.68-0.15-0.88-0.140.280.660.780.890.540.420.650.610.550.80.990.320.810.540.74
0.950.870.89-0.150.980.940.93-0.77-0.890.660.860.940.850.890.940.930.940.610.890.890.70.910.950.940.96
0.970.750.89-0.530.870.90.91-0.78-0.730.70.860.910.880.770.960.890.890.550.890.790.630.920.830.970.83
0.810.930.88-0.030.780.730.89-0.66-0.940.410.750.850.880.950.790.720.90.80.890.790.860.680.950.80.91
0.650.940.820.070.620.50.76-0.25-0.93-0.020.390.740.840.940.630.520.730.990.70.630.860.430.880.630.81
0.950.630.77-0.370.940.980.83-0.87-0.640.860.920.850.720.660.960.960.840.320.910.920.680.430.760.960.78
0.880.980.93-0.070.890.80.94-0.59-0.980.410.710.930.920.990.850.820.930.810.950.830.950.880.760.860.99
1.00.770.9-0.350.940.970.92-0.8-0.780.720.890.940.870.81.00.960.930.540.940.970.80.630.960.860.85
0.870.960.92-0.110.910.820.94-0.58-0.950.450.70.940.90.960.850.860.920.740.960.830.910.810.780.990.85
Click cells to compare fundamentals

IGM Biosciences Account Relationship Matchups

IGM Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets261.4M408.6M298.1M513.5M423.4M300.2M
Other Current Liab3.3M4.0M15.6M27.8M31.5M33.1M
Total Current Liabilities8.9M17.2M27.8M44.7M42.5M23.7M
Total Stockholder Equity(107.2M)(188.6M)(353.7M)(574.8M)203.2M213.4M
Net Tangible Assets240.2M381.8M244.9M287.3M330.4M192.1M
Property Plant And Equipment Net18.0M34.8M56.3M73.1M74.0M40.6M
Net Debt(21.2M)(228.8M)(104.6M)(80.1M)(72.0M)(75.6M)
Retained Earnings(107.2M)(188.6M)(353.7M)(574.8M)(821.2M)(780.2M)
Accounts Payable3.1M7.9M5.6M2.5M1.3M1.3M
Cash35.9M241.1M133.3M121.2M112.5M101.6M
Non Current Assets Total30.3M35.4M57.4M75.1M75.8M43.4M
Non Currrent Assets Other258K548K1.0M2.0M1.8M913.3K
Other Assets258K548K1.0M2.0M2.3M2.4M
Cash And Short Term Investments236.6M366.3M229.5M427.2M337.7M251.4M
Common Stock Shares Outstanding9.0M30.7M33.5M41.5M52.3M26.4M
Short Term Investments188.7M125.2M96.2M305.9M225.2M147.9M
Liabilities And Stockholders Equity(86.1M)(161.7M)(300.5M)(348.6M)423.4M444.6M
Non Current Liabilities Total12.2M9.6M25.4M181.6M177.7M186.6M
Capital Surpluse751K347.1M570.0M598.4M688.1M722.5M
Capital Lease Obligations14.7M12.2M28.8M41.2M40.5M21.6M
Other Current Assets6.4M14.0M11.2M21.3M9.9M10.0M
Other Stockholder Equity(261.7M)570.0M598.4M862.4M1.0B1.1B
Total Liab21.1M26.8M53.2M226.2M220.2M231.2M
Net Invested Capital240.2M381.8M244.9M287.3M203.2M197.4M
Property Plant And Equipment Gross18.0M34.8M62.9M85.4M94.6M99.3M
Total Current Assets231.1M373.3M240.7M438.4M347.6M256.8M
Accumulated Other Comprehensive Income43K26K(66K)(701K)151K158.6K
Net Working Capital222.2M356.0M213.0M393.7M305.1M233.1M
Short Term Debt2.5M5.3M6.6M11.6M5.8M5.8M
Common Stock304K319K325K431K331K270.0K
Property Plant Equipment18.0M34.8M28.5M73.1M84.0M88.2M
Short Long Term Debt Total14.7M12.2M28.8M41.2M40.5M26.1M
Capital Stock304K319K325K431K586K361.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for IGM Stock Analysis

When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.